Immunogenicity and Acceptance of Influenza A (H1N1) Vaccine in a Cohort of Chronic Hepatitis C Patients Receiving Pegylated-Interferon Treatment

• Manuel Hernández-Guerra ,

  * E-mail: mhernandezguerra@gmail.com

  Affiliations Liver Unit, University Hospital of the Canary Islands, Tenerife, Spain, Research Unit, University Hospital of the Canary Islands, Tenerife, Spain

  ⨯
• Yanira González-Méndez,

  Affiliation Liver Unit, University Hospital of the Canary Islands, Tenerife, Spain

  ⨯
• Patricia de Molina,

  Affiliation Barcelona Centre for International Health Research (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain

  ⨯
• Antonio Z. Gimeno-García,

  Affiliation Liver Unit, University Hospital of the Canary Islands, Tenerife, Spain

  ⨯
• Marta Carrillo,

  Affiliation Liver Unit, University Hospital of the Canary Islands, Tenerife, Spain

  ⨯
• Carlos Casanova,

  Affiliation Liver Unit, University Hospital of the Canary Islands, Tenerife, Spain

  ⨯
• Tomás Pumarola,

  Affiliations Barcelona Centre for International Health Research (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain, Department of Clinical Microbiology, Hospital Clínic, School of Medicine, University of Barcelona, Barcelona, Spain

  ⨯
• Alejandro Jimenez,

  Affiliation Research Unit, University Hospital of the Canary Islands, Tenerife, Spain

  ⨯
• Miriam Hernández-Porto,

  Affiliation Preventive Medicine and Public Health Department, University of La Laguna, Tenerife, Spain

  ⨯
• Álvaro Torres,

  Affiliation Preventive Medicine and Public Health Department, University of La Laguna, Tenerife, Spain

  ⨯
• Enrique Quintero

  Affiliations Liver Unit, University Hospital of the Canary Islands, Tenerife, Spain, Research Unit, University Hospital of the Canary Islands, Tenerife, Spain

  ⨯